Suppr超能文献

Cavidi ExaVir 病毒载量检测法和超敏 P24 检测法与罗氏 Monitor HIV-1 RNA 检测法的性能特征比较。

Performance characteristics of the Cavidi ExaVir viral load assay and the ultra-sensitive P24 assay relative to the Roche Monitor HIV-1 RNA assay.

机构信息

The University of North Carolina at Chapel Hill, Department of Biostatistics, Chapel Hill, NC 27599-7420, USA. paul

出版信息

J Clin Virol. 2010 Nov;49(3):198-204. doi: 10.1016/j.jcv.2010.07.022. Epub 2010 Sep 15.

Abstract

BACKGROUND

The Cavidi viral load assay and the ultra-sensitive p24 antigen assay (Up24 Ag) have been suggested as more feasible alternatives to PCR-based HIV viral load assays for use in monitoring patients infected with HIV-1 in resource-limited settings.

OBJECTIVES

To describe the performance of the Cavidi ExaVir Load™ assay (version 2.0) and two versions of the Up24 antigen assay and to characterize their agreement with the Roche Monitor HIV-1 RNA assay (version 1.5).

STUDY DESIGN

Observational study using a convenience sample of 342 plasma specimens from 108 patients enrolled in two ACTG clinical trials to evaluate the performance characteristics of the Up24 Ag assay using two different lysis buffers and the Cavidi ExaVir Load™ assay.

RESULTS

In analysis of agreement with the Roche assay, the Cavidi assay demonstrated superiority to the Up24 Ag assays in accuracy and precision, as well as sensitivity, specificity, and positive and negative predictive values for HIV-1 RNA ≥ 400, ≥ 1000 and ≥ 5000 copies/mL. Logistic performance curves indicated that the Cavidi assay was superior to the Up24 assays for viral loads greater than 650 copies/mL.

CONCLUSIONS

The results suggest that the Cavidi ExaVir Load assay could be used for monitoring HIV-1 viral load in resource-limited settings.

摘要

背景

Cavidi 病毒载量检测法和超灵敏 p24 抗原检测法(Up24Ag)被认为是在资源有限的环境中替代基于 PCR 的 HIV 病毒载量检测法来监测感染 HIV-1 患者的更可行的选择。

目的

描述 Cavidi ExaVir Load™检测法(版本 2.0)和两种 Up24 抗原检测法的性能,并描述它们与罗氏 Monitor HIV-1 RNA 检测法(版本 1.5)的一致性。

研究设计

采用方便样本的观察性研究,共纳入了两项 ACTG 临床试验中的 108 例患者的 342 份血浆标本,评估两种不同裂解缓冲液的 Up24Ag 检测法和 Cavidi ExaVir Load™检测法的性能特征。

结果

在与罗氏检测法的一致性分析中,Cavidi 检测法在准确性、精密度以及敏感性、特异性和 HIV-1 RNA≥400、≥1000 和≥5000 拷贝/ml 的阳性和阴性预测值方面优于 Up24Ag 检测法。逻辑性能曲线表明,对于病毒载量大于 650 拷贝/ml 的样本,Cavidi 检测法优于 Up24 检测法。

结论

研究结果表明,Cavidi ExaVir Load 检测法可用于资源有限环境中的 HIV-1 病毒载量监测。

相似文献

2
Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay.
J Clin Microbiol. 2005 Dec;43(12):5950-6. doi: 10.1128/JCM.43.12.5950-5956.2005.
5
Assessment of the Cavidi ExaVir Load Assay for Monitoring Plasma Viral Load in HIV-2-Infected Patients.
J Clin Microbiol. 2017 Aug;55(8):2367-2379. doi: 10.1128/JCM.00235-17. Epub 2017 May 17.
8
Assessment of the low-cost Cavidi ExaVir Load assay for monitoring HIV viral load in pediatric and adult patients.
J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):387-90. doi: 10.1097/QAI.0b013e3181b05f62.
9
Evaluation of the Cavidi ExaVir Load assay (version 3) for plasma human immunodeficiency virus type 1 load monitoring.
J Clin Microbiol. 2009 Sep;47(9):3011-3. doi: 10.1128/JCM.00805-09. Epub 2009 Jul 15.

引用本文的文献

1
Assessment of the Cavidi ExaVir Load Assay for Monitoring Plasma Viral Load in HIV-2-Infected Patients.
J Clin Microbiol. 2017 Aug;55(8):2367-2379. doi: 10.1128/JCM.00235-17. Epub 2017 May 17.
4
A lateral flow assay for quantitative detection of amplified HIV-1 RNA.
PLoS One. 2012;7(9):e45611. doi: 10.1371/journal.pone.0045611. Epub 2012 Sep 21.
5
Early detection of HIV infection among Kenyan infants using a reverse transcriptase activity assay.
Pediatr Infect Dis J. 2012 Jul;31(7):732-5. doi: 10.1097/INF.0b013e318259bc1e.
6
Low-cost assays for monitoring HIV infected individuals in resource-limited settings.
Indian J Med Res. 2011 Dec;134(6):823-34. doi: 10.4103/0971-5916.92628.

本文引用的文献

1
Simple amplification-based assay: a nucleic acid-based point-of-care platform for HIV-1 testing.
J Infect Dis. 2010 Apr 15;201 Suppl 1:S65-72. doi: 10.1086/650385.
2
Effect of reverse transcriptase inhibitors and mutations on the low-cost Cavidi reverse transcriptase viral load assay.
J Acquir Immune Defic Syndr. 2009 Dec 1;52(4):527-9. doi: 10.1097/QAI.0b013e3181b9e726.
6
Assessment of the low-cost Cavidi ExaVir Load assay for monitoring HIV viral load in pediatric and adult patients.
J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):387-90. doi: 10.1097/QAI.0b013e3181b05f62.
7
Evaluation of the Cavidi ExaVir Load assay (version 3) for plasma human immunodeficiency virus type 1 load monitoring.
J Clin Microbiol. 2009 Sep;47(9):3011-3. doi: 10.1128/JCM.00805-09. Epub 2009 Jul 15.
9
Development of phenotypic HIV-1 drug resistance after exposure to single-dose nevirapine.
J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):538-43. doi: 10.1097/QAI.0b013e31818d5dcf.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验